Development of a urine-based metabolomics approach for multi-cancer screening and tumor origin prediction.
Journal:
Frontiers in immunology
PMID:
39735533
Abstract
BACKGROUND: Cancer remains a leading cause of mortality worldwide. A non-invasive screening solution was required for early diagnosis of cancer. Multi-cancer early detection (MCED) tests have been considered to address the challenge by simultaneously identifying multiple types of cancer within a single test using minimally invasive blood samples. However, a multi-cancer screening strategy utilizing urine-based metabolomics has not yet been developed.